HEADER TRANSFERASE 19-FEB-19 6QRM TITLE HSNMT1 IN COMPLEX WITH BOTH MYRCOA AND GNCFSKRRAA SUBSTRATES COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRANSFERASE 1,TYPE I N- COMPND 5 MYRISTOYLTRANSFERASE,PEPTIDE N-MYRISTOYLTRANSFERASE 1; COMPND 6 EC: 2.3.1.97; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: APOPTOSIS-INDUCING FACTOR 3; COMPND 10 CHAIN: C, D; COMPND 11 SYNONYM: APOPTOSIS-INDUCING FACTOR-LIKE PROTEIN; COMPND 12 EC: 1.-.-.-; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES; COMPND 15 OTHER_DETAILS: PEPTIDE MYRISTOYLATED WITHIN THE CRYSTAL SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NMT1, NMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 DERIVATIVE; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606 KEYWDS MYRISTOYLTRANSFERASE TYPE1, ACYLTRANSFERASE, GNAT, GCN5-RELATED N- KEYWDS 2 ACETYLTRANSFERASES, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.DIAN,F.B.RIVIERE,T.ASENSIO,C.GIGLIONE,T.MEINNEL REVDAT 2 24-JAN-24 6QRM 1 REMARK REVDAT 1 18-MAR-20 6QRM 0 JRNL AUTH C.DIAN,I.PEREZ-DORADO,F.RIVIERE,T.ASENSIO,P.LEGRAND, JRNL AUTH 2 M.RITZEFELD,M.SHEN,E.COTA,T.MEINNEL,E.W.TATE,C.GIGLIONE JRNL TITL HIGH-RESOLUTION SNAPSHOTS OF HUMAN N-MYRISTOYLTRANSFERASE IN JRNL TITL 2 ACTION ILLUMINATE A MECHANISM PROMOTING N-TERMINAL LYS AND JRNL TITL 3 GLY MYRISTOYLATION. JRNL REF NAT COMMUN V. 11 1132 2020 JRNL REFN ESSN 2041-1723 JRNL PMID 32111831 JRNL DOI 10.1038/S41467-020-14847-3 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.91 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.120 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 71165 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 3606 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.9100 - 6.8080 1.00 2593 161 0.1709 0.1817 REMARK 3 2 6.8080 - 5.4059 1.00 2606 132 0.1838 0.2129 REMARK 3 3 5.4059 - 4.7232 1.00 2600 141 0.1380 0.1519 REMARK 3 4 4.7232 - 4.2916 1.00 2620 134 0.1241 0.1574 REMARK 3 5 4.2916 - 3.9842 0.94 2452 128 0.1282 0.1618 REMARK 3 6 3.9842 - 3.7494 1.00 2587 162 0.1488 0.1817 REMARK 3 7 3.7494 - 3.5617 1.00 2578 171 0.1499 0.1911 REMARK 3 8 3.5617 - 3.4067 1.00 2618 126 0.1510 0.1544 REMARK 3 9 3.4067 - 3.2755 1.00 2632 133 0.1564 0.1586 REMARK 3 10 3.2755 - 3.1625 1.00 2628 117 0.1585 0.1856 REMARK 3 11 3.1625 - 3.0637 1.00 2604 127 0.1773 0.2229 REMARK 3 12 3.0637 - 2.9761 1.00 2606 170 0.1719 0.1959 REMARK 3 13 2.9761 - 2.8978 1.00 2600 144 0.1769 0.2042 REMARK 3 14 2.8978 - 2.8271 1.00 2590 131 0.1827 0.2421 REMARK 3 15 2.8271 - 2.7628 1.00 2616 135 0.1885 0.2529 REMARK 3 16 2.7628 - 2.7040 1.00 2658 137 0.1869 0.2415 REMARK 3 17 2.7040 - 2.6499 1.00 2540 127 0.1943 0.2509 REMARK 3 18 2.6499 - 2.5999 1.00 2635 143 0.2020 0.2617 REMARK 3 19 2.5999 - 2.5535 1.00 2596 136 0.2099 0.2042 REMARK 3 20 2.5535 - 2.5102 1.00 2608 135 0.2081 0.2576 REMARK 3 21 2.5102 - 2.4697 0.99 2608 139 0.2256 0.3063 REMARK 3 22 2.4697 - 2.4317 1.00 2567 154 0.2353 0.2905 REMARK 3 23 2.4317 - 2.3960 0.99 2616 125 0.2475 0.3173 REMARK 3 24 2.3960 - 2.3622 1.00 2625 142 0.2720 0.2823 REMARK 3 25 2.3622 - 2.3303 1.00 2586 131 0.2810 0.2996 REMARK 3 26 2.3303 - 2.3000 0.99 2590 125 0.2862 0.3574 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.550 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.09 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 6786 REMARK 3 ANGLE : 0.992 9229 REMARK 3 CHIRALITY : 0.059 1007 REMARK 3 PLANARITY : 0.006 1159 REMARK 3 DIHEDRAL : 15.970 4068 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6QRM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-FEB-19. REMARK 100 THE DEPOSITION ID IS D_1292100632. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-FEB-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.967700 REMARK 200 MONOCHROMATOR : SI (111) CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER R 4M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 75369 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 48.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 9.200 REMARK 200 R MERGE (I) : 0.14300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 9.40 REMARK 200 R MERGE FOR SHELL (I) : 0.66900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5O9V REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG8K, 100MM SODIUM CITRATE PH REMARK 280 5.5, 100MM MGCL2, 100MM NACL., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 39.71850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 89.46550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.71850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 89.46550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 95 REMARK 465 GLY A 96 REMARK 465 SER A 97 REMARK 465 GLU A 98 REMARK 465 PHE A 99 REMARK 465 SER A 100 REMARK 465 VAL A 101 REMARK 465 GLY A 102 REMARK 465 GLN A 103 REMARK 465 GLY A 104 REMARK 465 GLY B 95 REMARK 465 GLY B 96 REMARK 465 SER B 97 REMARK 465 GLU B 98 REMARK 465 PHE B 99 REMARK 465 SER B 100 REMARK 465 VAL B 101 REMARK 465 GLY B 102 REMARK 465 GLN B 103 REMARK 465 GLY B 104 REMARK 465 ARG B 316 REMARK 465 ALA C 9 REMARK 465 ALA C 10 REMARK 465 ALA D 10 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 110 CG CD OE1 OE2 REMARK 470 GLU A 111 CG CD OE1 OE2 REMARK 470 LYS A 114 CG CD CE NZ REMARK 470 GLN A 118 CG CD OE1 NE2 REMARK 470 ARG A 166 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 304 CG CD NE CZ NH1 NH2 REMARK 470 SER A 315 OG REMARK 470 ARG A 316 CB CG CD NE CZ NH1 NH2 REMARK 470 GLN A 321 CG CD OE1 NE2 REMARK 470 LYS A 325 CG CD CE NZ REMARK 470 ARG A 328 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 110 CG CD OE1 OE2 REMARK 470 GLN B 118 CG CD OE1 NE2 REMARK 470 LYS B 127 CG CD CE NZ REMARK 470 ARG B 166 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 308 CG CD OE1 OE2 REMARK 470 LYS B 310 CG CD CE NZ REMARK 470 GLN B 321 CG CD OE1 NE2 REMARK 470 LYS B 325 CG CD CE NZ REMARK 470 ARG B 328 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 414 CG CD CE NZ REMARK 470 ARG C 7 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 8 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 6 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ARG A 328 O HOH A 601 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 117 79.04 -115.42 REMARK 500 TYR A 180 -157.48 -87.91 REMARK 500 TYR A 236 -118.02 53.94 REMARK 500 ILE A 381 -66.21 -131.28 REMARK 500 PHE A 422 -100.74 -114.86 REMARK 500 GLN A 428 -43.54 -132.84 REMARK 500 MET A 456 -130.76 48.58 REMARK 500 LYS A 466 32.86 77.18 REMARK 500 ASN B 144 101.60 -160.13 REMARK 500 HIS B 211 78.62 -107.38 REMARK 500 TYR B 236 -115.07 50.47 REMARK 500 LEU B 314 105.89 -47.02 REMARK 500 PHE B 422 -102.16 -107.36 REMARK 500 GLN B 428 -50.56 -129.36 REMARK 500 MET B 456 -136.96 53.54 REMARK 500 ASN C 2 -178.07 -64.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 798 DISTANCE = 5.97 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue COA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYA B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide MYR C 101 and GLY C REMARK 800 1 DBREF 6QRM A 99 496 UNP P30419 NMT1_HUMAN 99 496 DBREF 6QRM B 99 496 UNP P30419 NMT1_HUMAN 99 496 DBREF 6QRM C 1 10 UNP Q96NN9 AIFM3_HUMAN 2 11 DBREF 6QRM D 1 10 UNP Q96NN9 AIFM3_HUMAN 2 11 SEQADV 6QRM GLY A 95 UNP P30419 EXPRESSION TAG SEQADV 6QRM GLY A 96 UNP P30419 EXPRESSION TAG SEQADV 6QRM SER A 97 UNP P30419 EXPRESSION TAG SEQADV 6QRM GLU A 98 UNP P30419 EXPRESSION TAG SEQADV 6QRM GLY B 95 UNP P30419 EXPRESSION TAG SEQADV 6QRM GLY B 96 UNP P30419 EXPRESSION TAG SEQADV 6QRM SER B 97 UNP P30419 EXPRESSION TAG SEQADV 6QRM GLU B 98 UNP P30419 EXPRESSION TAG SEQADV 6QRM ASN C 2 UNP Q96NN9 GLY 3 ENGINEERED MUTATION SEQADV 6QRM ARG C 7 UNP Q96NN9 PRO 8 ENGINEERED MUTATION SEQADV 6QRM ARG C 8 UNP Q96NN9 LYS 9 CONFLICT SEQADV 6QRM ALA C 9 UNP Q96NN9 PRO 10 CONFLICT SEQADV 6QRM ALA C 10 UNP Q96NN9 VAL 11 CONFLICT SEQADV 6QRM ASN D 2 UNP Q96NN9 GLY 3 ENGINEERED MUTATION SEQADV 6QRM ARG D 7 UNP Q96NN9 PRO 8 ENGINEERED MUTATION SEQADV 6QRM ARG D 8 UNP Q96NN9 LYS 9 CONFLICT SEQADV 6QRM ALA D 9 UNP Q96NN9 PRO 10 CONFLICT SEQADV 6QRM ALA D 10 UNP Q96NN9 VAL 11 CONFLICT SEQRES 1 A 402 GLY GLY SER GLU PHE SER VAL GLY GLN GLY PRO ALA LYS SEQRES 2 A 402 THR MET GLU GLU ALA SER LYS ARG SER TYR GLN PHE TRP SEQRES 3 A 402 ASP THR GLN PRO VAL PRO LYS LEU GLY GLU VAL VAL ASN SEQRES 4 A 402 THR HIS GLY PRO VAL GLU PRO ASP LYS ASP ASN ILE ARG SEQRES 5 A 402 GLN GLU PRO TYR THR LEU PRO GLN GLY PHE THR TRP ASP SEQRES 6 A 402 ALA LEU ASP LEU GLY ASP ARG GLY VAL LEU LYS GLU LEU SEQRES 7 A 402 TYR THR LEU LEU ASN GLU ASN TYR VAL GLU ASP ASP ASP SEQRES 8 A 402 ASN MET PHE ARG PHE ASP TYR SER PRO GLU PHE LEU LEU SEQRES 9 A 402 TRP ALA LEU ARG PRO PRO GLY TRP LEU PRO GLN TRP HIS SEQRES 10 A 402 CYS GLY VAL ARG VAL VAL SER SER ARG LYS LEU VAL GLY SEQRES 11 A 402 PHE ILE SER ALA ILE PRO ALA ASN ILE HIS ILE TYR ASP SEQRES 12 A 402 THR GLU LYS LYS MET VAL GLU ILE ASN PHE LEU CYS VAL SEQRES 13 A 402 HIS LYS LYS LEU ARG SER LYS ARG VAL ALA PRO VAL LEU SEQRES 14 A 402 ILE ARG GLU ILE THR ARG ARG VAL HIS LEU GLU GLY ILE SEQRES 15 A 402 PHE GLN ALA VAL TYR THR ALA GLY VAL VAL LEU PRO LYS SEQRES 16 A 402 PRO VAL GLY THR CYS ARG TYR TRP HIS ARG SER LEU ASN SEQRES 17 A 402 PRO ARG LYS LEU ILE GLU VAL LYS PHE SER HIS LEU SER SEQRES 18 A 402 ARG ASN MET THR MET GLN ARG THR MET LYS LEU TYR ARG SEQRES 19 A 402 LEU PRO GLU THR PRO LYS THR ALA GLY LEU ARG PRO MET SEQRES 20 A 402 GLU THR LYS ASP ILE PRO VAL VAL HIS GLN LEU LEU THR SEQRES 21 A 402 ARG TYR LEU LYS GLN PHE HIS LEU THR PRO VAL MET SER SEQRES 22 A 402 GLN GLU GLU VAL GLU HIS TRP PHE TYR PRO GLN GLU ASN SEQRES 23 A 402 ILE ILE ASP THR PHE VAL VAL GLU ASN ALA ASN GLY GLU SEQRES 24 A 402 VAL THR ASP PHE LEU SER PHE TYR THR LEU PRO SER THR SEQRES 25 A 402 ILE MET ASN HIS PRO THR HIS LYS SER LEU LYS ALA ALA SEQRES 26 A 402 TYR SER PHE TYR ASN VAL HIS THR GLN THR PRO LEU LEU SEQRES 27 A 402 ASP LEU MET SER ASP ALA LEU VAL LEU ALA LYS MET LYS SEQRES 28 A 402 GLY PHE ASP VAL PHE ASN ALA LEU ASP LEU MET GLU ASN SEQRES 29 A 402 LYS THR PHE LEU GLU LYS LEU LYS PHE GLY ILE GLY ASP SEQRES 30 A 402 GLY ASN LEU GLN TYR TYR LEU TYR ASN TRP LYS CYS PRO SEQRES 31 A 402 SER MET GLY ALA GLU LYS VAL GLY LEU VAL LEU GLN SEQRES 1 B 402 GLY GLY SER GLU PHE SER VAL GLY GLN GLY PRO ALA LYS SEQRES 2 B 402 THR MET GLU GLU ALA SER LYS ARG SER TYR GLN PHE TRP SEQRES 3 B 402 ASP THR GLN PRO VAL PRO LYS LEU GLY GLU VAL VAL ASN SEQRES 4 B 402 THR HIS GLY PRO VAL GLU PRO ASP LYS ASP ASN ILE ARG SEQRES 5 B 402 GLN GLU PRO TYR THR LEU PRO GLN GLY PHE THR TRP ASP SEQRES 6 B 402 ALA LEU ASP LEU GLY ASP ARG GLY VAL LEU LYS GLU LEU SEQRES 7 B 402 TYR THR LEU LEU ASN GLU ASN TYR VAL GLU ASP ASP ASP SEQRES 8 B 402 ASN MET PHE ARG PHE ASP TYR SER PRO GLU PHE LEU LEU SEQRES 9 B 402 TRP ALA LEU ARG PRO PRO GLY TRP LEU PRO GLN TRP HIS SEQRES 10 B 402 CYS GLY VAL ARG VAL VAL SER SER ARG LYS LEU VAL GLY SEQRES 11 B 402 PHE ILE SER ALA ILE PRO ALA ASN ILE HIS ILE TYR ASP SEQRES 12 B 402 THR GLU LYS LYS MET VAL GLU ILE ASN PHE LEU CYS VAL SEQRES 13 B 402 HIS LYS LYS LEU ARG SER LYS ARG VAL ALA PRO VAL LEU SEQRES 14 B 402 ILE ARG GLU ILE THR ARG ARG VAL HIS LEU GLU GLY ILE SEQRES 15 B 402 PHE GLN ALA VAL TYR THR ALA GLY VAL VAL LEU PRO LYS SEQRES 16 B 402 PRO VAL GLY THR CYS ARG TYR TRP HIS ARG SER LEU ASN SEQRES 17 B 402 PRO ARG LYS LEU ILE GLU VAL LYS PHE SER HIS LEU SER SEQRES 18 B 402 ARG ASN MET THR MET GLN ARG THR MET LYS LEU TYR ARG SEQRES 19 B 402 LEU PRO GLU THR PRO LYS THR ALA GLY LEU ARG PRO MET SEQRES 20 B 402 GLU THR LYS ASP ILE PRO VAL VAL HIS GLN LEU LEU THR SEQRES 21 B 402 ARG TYR LEU LYS GLN PHE HIS LEU THR PRO VAL MET SER SEQRES 22 B 402 GLN GLU GLU VAL GLU HIS TRP PHE TYR PRO GLN GLU ASN SEQRES 23 B 402 ILE ILE ASP THR PHE VAL VAL GLU ASN ALA ASN GLY GLU SEQRES 24 B 402 VAL THR ASP PHE LEU SER PHE TYR THR LEU PRO SER THR SEQRES 25 B 402 ILE MET ASN HIS PRO THR HIS LYS SER LEU LYS ALA ALA SEQRES 26 B 402 TYR SER PHE TYR ASN VAL HIS THR GLN THR PRO LEU LEU SEQRES 27 B 402 ASP LEU MET SER ASP ALA LEU VAL LEU ALA LYS MET LYS SEQRES 28 B 402 GLY PHE ASP VAL PHE ASN ALA LEU ASP LEU MET GLU ASN SEQRES 29 B 402 LYS THR PHE LEU GLU LYS LEU LYS PHE GLY ILE GLY ASP SEQRES 30 B 402 GLY ASN LEU GLN TYR TYR LEU TYR ASN TRP LYS CYS PRO SEQRES 31 B 402 SER MET GLY ALA GLU LYS VAL GLY LEU VAL LEU GLN SEQRES 1 C 10 GLY ASN CYS PHE SER LYS ARG ARG ALA ALA SEQRES 1 D 10 GLY ASN CYS PHE SER LYS ARG ARG ALA ALA HET COA A 501 48 HET GOL A 502 6 HET GOL A 503 6 HET CL A 504 1 HET MYA B 501 63 HET GOL B 502 6 HET GOL B 503 6 HET CL B 504 1 HET MYR C 101 15 HETNAM COA COENZYME A HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETNAM MYA TETRADECANOYL-COA HETNAM MYR MYRISTIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN MYA MYRISTOYL-COA FORMUL 5 COA C21 H36 N7 O16 P3 S FORMUL 6 GOL 4(C3 H8 O3) FORMUL 8 CL 2(CL 1-) FORMUL 9 MYA C35 H62 N7 O17 P3 S FORMUL 13 MYR C14 H28 O2 FORMUL 14 HOH *396(H2 O) HELIX 1 AA1 THR A 108 LYS A 114 1 7 HELIX 2 AA2 PHE A 119 GLN A 123 5 5 HELIX 3 AA3 ASP A 165 TYR A 180 1 16 HELIX 4 AA4 SER A 193 ARG A 202 1 10 HELIX 5 AA5 LEU A 207 GLN A 209 5 3 HELIX 6 AA6 LYS A 252 ARG A 255 5 4 HELIX 7 AA7 ARG A 258 LEU A 273 1 16 HELIX 8 AA8 ASN A 302 VAL A 309 1 8 HELIX 9 AA9 THR A 319 TYR A 327 1 9 HELIX 10 AB1 GLU A 342 LYS A 344 5 3 HELIX 11 AB2 ASP A 345 LYS A 358 1 14 HELIX 12 AB3 SER A 367 TYR A 376 1 10 HELIX 13 AB4 PRO A 430 LYS A 445 1 16 HELIX 14 AB5 ASN A 458 GLU A 463 1 6 HELIX 15 AB6 GLY A 487 VAL A 491 5 5 HELIX 16 AB7 THR B 108 ARG B 115 1 8 HELIX 17 AB8 PHE B 119 GLN B 123 5 5 HELIX 18 AB9 ASP B 165 TYR B 180 1 16 HELIX 19 AC1 SER B 193 ARG B 202 1 10 HELIX 20 AC2 LEU B 207 GLN B 209 5 3 HELIX 21 AC3 LYS B 252 ARG B 255 5 4 HELIX 22 AC4 ARG B 258 GLU B 274 1 17 HELIX 23 AC5 ASN B 302 VAL B 309 1 8 HELIX 24 AC6 THR B 319 ARG B 328 1 10 HELIX 25 AC7 GLU B 342 LYS B 344 5 3 HELIX 26 AC8 ASP B 345 LYS B 358 1 14 HELIX 27 AC9 SER B 367 TYR B 376 1 10 HELIX 28 AD1 PRO B 430 LYS B 445 1 16 HELIX 29 AD2 GLU B 457 PHE B 461 5 5 HELIX 30 AD3 GLY B 487 VAL B 491 5 5 SHEET 1 AA112 PHE A 156 ALA A 160 0 SHEET 2 AA112 HIS A 211 VAL A 216 -1 O ARG A 215 N THR A 157 SHEET 3 AA112 LEU A 222 ILE A 235 -1 O VAL A 223 N VAL A 214 SHEET 4 AA112 THR A 238 VAL A 250 -1 O LYS A 240 N ILE A 233 SHEET 5 AA112 ALA A 279 ALA A 283 1 O VAL A 280 N VAL A 243 SHEET 6 AA112 GLY A 468 TYR A 479 -1 O TYR A 479 N ALA A 279 SHEET 7 AA112 GLY A 292 SER A 300 -1 N HIS A 298 O GLY A 468 SHEET 8 AA112 VAL A 449 LEU A 453 -1 O ALA A 452 N TRP A 297 SHEET 9 AA112 ALA A 418 SER A 421 1 N ALA A 419 O ASN A 451 SHEET 10 AA112 VAL A 394 THR A 402 -1 N TYR A 401 O TYR A 420 SHEET 11 AA112 ILE A 382 GLU A 388 -1 N ASP A 383 O PHE A 400 SHEET 12 AA112 LEU A 338 PRO A 340 -1 N ARG A 339 O VAL A 386 SHEET 1 AA2 4 PHE A 156 ALA A 160 0 SHEET 2 AA2 4 HIS A 211 VAL A 216 -1 O ARG A 215 N THR A 157 SHEET 3 AA2 4 LEU A 222 ILE A 235 -1 O VAL A 223 N VAL A 214 SHEET 4 AA2 4 LEU A 362 VAL A 365 -1 O THR A 363 N HIS A 234 SHEET 1 AA3 3 PHE A 188 PHE A 190 0 SHEET 2 AA3 3 SER A 405 ILE A 407 -1 O THR A 406 N ARG A 189 SHEET 3 AA3 3 SER A 415 LEU A 416 -1 O LEU A 416 N SER A 405 SHEET 1 AA412 PHE B 156 ALA B 160 0 SHEET 2 AA412 HIS B 211 VAL B 216 -1 O ARG B 215 N THR B 157 SHEET 3 AA412 LEU B 222 ILE B 235 -1 O VAL B 223 N VAL B 214 SHEET 4 AA412 THR B 238 VAL B 250 -1 O THR B 238 N ILE B 235 SHEET 5 AA412 ALA B 279 ALA B 283 1 O VAL B 280 N VAL B 243 SHEET 6 AA412 GLY B 468 TYR B 479 -1 O TYR B 477 N TYR B 281 SHEET 7 AA412 GLY B 292 SER B 300 -1 N HIS B 298 O GLY B 468 SHEET 8 AA412 VAL B 449 LEU B 453 -1 O ALA B 452 N TRP B 297 SHEET 9 AA412 ALA B 418 SER B 421 1 N ALA B 419 O ASN B 451 SHEET 10 AA412 VAL B 394 THR B 402 -1 N TYR B 401 O TYR B 420 SHEET 11 AA412 ILE B 382 GLU B 388 -1 N VAL B 387 O ASP B 396 SHEET 12 AA412 LEU B 338 PRO B 340 -1 N ARG B 339 O VAL B 386 SHEET 1 AA5 4 PHE B 156 ALA B 160 0 SHEET 2 AA5 4 HIS B 211 VAL B 216 -1 O ARG B 215 N THR B 157 SHEET 3 AA5 4 LEU B 222 ILE B 235 -1 O VAL B 223 N VAL B 214 SHEET 4 AA5 4 LEU B 362 VAL B 365 -1 O THR B 363 N HIS B 234 SHEET 1 AA6 2 PHE B 188 PHE B 190 0 SHEET 2 AA6 2 SER B 405 ILE B 407 -1 O THR B 406 N ARG B 189 LINK N GLY C 1 C1 MYR C 101 1555 1555 1.32 CISPEP 1 PRO A 288 LYS A 289 0 -8.76 CISPEP 2 PRO B 288 LYS B 289 0 -12.16 SITE 1 AC1 23 ARG A 115 TYR A 117 GLN A 118 PHE A 119 SITE 2 AC1 23 TRP A 120 ASN A 179 TYR A 180 VAL A 181 SITE 3 AC1 23 LEU A 248 CYS A 249 VAL A 250 ARG A 255 SITE 4 AC1 23 SER A 256 LYS A 257 ARG A 258 VAL A 259 SITE 5 AC1 23 ALA A 260 PRO A 261 ALA A 283 LEU A 287 SITE 6 AC1 23 HOH A 701 GLY C 1 MYR C 101 SITE 1 AC2 8 GLU A 244 MET A 366 TRP A 374 TYR A 423 SITE 2 AC2 8 LEU A 493 VAL A 494 LEU A 495 GLN A 496 SITE 1 AC3 8 LYS A 289 PRO A 290 VAL A 291 LEU A 478 SITE 2 AC3 8 TRP A 481 CYS A 483 HOH A 647 HOH A 743 SITE 1 AC4 4 LEU A 163 ARG A 202 TRP A 206 HIS A 211 SITE 1 AC5 32 ARG B 115 TYR B 117 GLN B 118 PHE B 119 SITE 2 AC5 32 TRP B 120 ASN B 179 TYR B 180 VAL B 181 SITE 3 AC5 32 ASN B 246 PHE B 247 LEU B 248 CYS B 249 SITE 4 AC5 32 VAL B 250 ARG B 255 SER B 256 LYS B 257 SITE 5 AC5 32 ARG B 258 VAL B 259 ALA B 260 PRO B 261 SITE 6 AC5 32 THR B 268 PHE B 277 ALA B 279 TYR B 281 SITE 7 AC5 32 THR B 282 LEU B 287 TYR B 479 HOH B 612 SITE 8 AC5 32 HOH B 644 HOH B 659 HOH B 731 GLY D 1 SITE 1 AC6 8 PRO B 126 LYS B 289 VAL B 291 LEU B 478 SITE 2 AC6 8 TRP B 481 LYS B 482 CYS B 483 HOH B 668 SITE 1 AC7 7 GLU B 244 TRP B 374 PHE B 422 TYR B 423 SITE 2 AC7 7 VAL B 494 GLN B 496 HOH B 689 SITE 1 AC8 4 LEU B 163 ARG B 202 TRP B 206 HIS B 211 SITE 1 AC9 14 TYR A 180 ILE A 245 ASN A 246 PHE A 247 SITE 2 AC9 14 LEU A 248 THR A 268 PHE A 277 ALA A 279 SITE 3 AC9 14 TYR A 281 THR A 282 ALA A 283 TYR A 479 SITE 4 AC9 14 COA A 501 ASN C 2 CRYST1 79.437 178.931 58.412 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012589 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005589 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017120 0.00000